{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T17:46:26Z","timestamp":1795283186715,"version":"4.10.3"},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1677,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1479-828x.2010.01269.x","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T04:49:02Z","timestamp":1296190142000},"page":"103-108","source":"Crossref","is-referenced-by-count":86,"title":["HPV infection and cervical disease: A review"],"prefix":"10.1111","volume":"51","author":[{"given":"Jonathan R.","family":"CARTER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongqun","family":"DING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara R.","family":"ROSE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,28]]},"reference":[{"key":"10.1111\/j.1479-828X.2010.01269.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.vaccine.2005.01.016","article-title":"Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control","volume":"23","author":"Franco","year":"2005","journal-title":"Vaccine"},{"key":"10.1111\/j.1479-828X.2010.01269.x-BIB2|cit2","volume-title":"Cervical Screening in Australia 2006-2007 Cancer series no. 47. Cat. no. CAN 43","author":"Australian Institute of Health and Welfare","year":"2009"},{"key":"10.1111\/j.1479-828X.2010.01269.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cncr.22751","article-title":"Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing","volume":"111","author":"Schiffman","year":"2007","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1111\/j.1479-828X.2010.01269.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajog.2004.01.042","article-title":"The health care costs of cervical human papillomavirus-related disease","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1111\/j.1479-828X.2010.01269.x-BIB5|cit5","first-page":"653","article-title":"Cancer screening. Prevention of cervical cancer","volume":"178","author":"Farnsworth","year":"2003","journal-title":"eMJA"},{"issue":"7 Suppl","key":"10.1111\/j.1479-828X.2010.01269.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/cncr.23704","article-title":"Human papillo-mavirus infection and the primary and secondary prevention of cervical cancer","volume":"113","author":"Lowy","year":"2008","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1111\/j.1479-828X.2010.01269.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.vaccine.2005.09.054","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24","author":"Trottier","year":"2006","journal-title":"Vaccine"},{"key":"10.1111\/j.1479-828X.2010.01269.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"issue":"6","key":"10.1111\/j.1479-828X.2010.01269.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1111\/j.1479-828X.2010.01269.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1479-828X.2010.01269.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0002-9378(69)90268-3","article-title":"A follow up study of patients with cervical dysplasia","volume":"105","author":"Richart","year":"1969","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1111\/j.1479-828X.2010.01269.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low grade cervical lesions: comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidermiol Biomarkers Prev"},{"key":"10.1111\/j.1479-828X.2010.01269.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ogc.2007.09.004","article-title":"Cervical cancer prevention-cervical screening: science in evolution","volume":"34","author":"Safaeian","year":"2007","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"4","key":"10.1111\/j.1479-828X.2010.01269.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/infdis\/174.4.679","article-title":"Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women","volume":"174","author":"Burk","year":"1996","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1111\/j.1479-828X.2010.01269.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0193841X04265651","article-title":"Passive versus active parental permission in school-based survey research: does the type of permission affect prevalence estimates of risk behaviors?","volume":"28","author":"Eaton","year":"2004","journal-title":"Eval Rev"},{"issue":"RR-12","key":"10.1111\/j.1479-828X.2010.01269.x-BIB16|cit16","first-page":"1","article-title":"Methodology of the youth risk behavior surveillance system","volume":"53","author":"Brener","year":"2004","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1111\/j.1479-828X.2010.01269.x-BIB17|cit17","first-page":"1","article-title":"Youth risk behavior surveillance - United States, 2003","volume":"53","author":"Grunbaum","year":"2004","journal-title":"MMWR Surveill Summ"},{"issue":"3","key":"10.1111\/j.1479-828X.2010.01269.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"5A","key":"10.1111\/j.1479-828X.2010.01269.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"issue":"7","key":"10.1111\/j.1479-828X.2010.01269.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bjc.6602088","article-title":"Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica","volume":"91","author":"Wang","year":"2004","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1111\/j.1479-828X.2010.01269.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1471-0528.2002.01053.x","article-title":"High incidence of cervical human papillomavirus infection in women during their first sexual relationship","volume":"109","author":"Collins","year":"2002","journal-title":"BJOG"},{"issue":"2","key":"10.1111\/j.1479-828X.2010.01269.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1055-9965.EPI-03-0166","article-title":"Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica","volume":"13","author":"Viscidi","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1111\/j.1479-828X.2010.01269.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1086\/315498","article-title":"Comparison of human papillomavirus types 16,18 and 6 capsid antibody responses following incident infection","volume":"18","author":"Carter","year":"2000","journal-title":"J Infect Dis"},{"issue":"1 Suppl","key":"10.1111\/j.1479-828X.2010.01269.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ygyno.2010.04.004","article-title":"Current understanding of the mechanism of HPV infection","volume":"118","author":"Schiller","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1111\/j.1479-828X.2010.01269.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/jcp.2006.040568","article-title":"Prophylactic HPV vaccines","volume":"60","author":"Stanley","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1479-828X.2010.01269.x-BIB26|cit26","first-page":"2","article-title":"A practitioner\u2019s guide to understanding immunity to human papillomavirus","author":"Stanley","year":"2009","journal-title":"Touch Brief"},{"issue":"15","key":"10.1111\/j.1479-828X.2010.01269.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jnci\/djg018","article-title":"Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles","volume":"95","author":"Nardelli-Haefliger","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1111\/j.1479-828X.2010.01269.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4161\/hv.5.10.9518","article-title":"Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45\u2003years","volume":"5","author":"Einstein","year":"2009","journal-title":"Hum Vaccin"},{"issue":"10","key":"10.1111\/j.1479-828X.2010.01269.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res"},{"issue":"Suppl 1","key":"10.1111\/j.1479-828X.2010.01269.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"A46","DOI":"10.1016\/j.vaccine.2008.10.085","article-title":"Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence","volume":"27","author":"Bonanni","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1111\/j.1479-828X.2010.01269.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"issue":"9679","key":"10.1111\/j.1479-828X.2010.01269.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45\u2003years: a randomised, double-blind trial","volume":"373","author":"Mu\u00f1oz","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1111\/j.1479-828X.2010.01269.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"Rodr\u00edguez","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"10.1111\/j.1479-828X.2010.01269.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1086\/522864","article-title":"Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection","volume":"196","author":"FUTURE II Study Group","year":"2007","journal-title":"J Infect Dis"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1479-828X.2010.01269.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1479-828X.2010.01269.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T17:09:16Z","timestamp":1625504956000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1479-828X.2010.01269.x"}},"subtitle":["HPV and cervical disease"],"short-title":[],"issued":{"date-parts":[[2011,1,28]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1479-828x.2010.01269.x","relation":{},"ISSN":["0004-8666"],"issn-type":[{"value":"0004-8666","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,28]]}}}